GILEAD SCIENCES, INC. 4

Johanna Mercier, Chief Comm & Corp Aff Officer of Gilead Sciences, Inc., sold 3,000 shares of GILD common stock on 2026-06-15 under a Rule 10b5-1 trading plan.

On June 15, 2026, Johanna Mercier, Chief Commercial & Corporate Affairs Officer of Gilead Sciences, Inc., sold an aggregate 3,000 shares of Gilead common stock in three open-market transactions executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 20, 2025. The sales consisted of 1,480 shares at approximately $123.42 per share, 1,070 shares at approximately $124.00 per share, and 450 shares at approximately $125.40 per share, for total proceeds of roughly $371,000. Following these sales, Mercier continued to hold approximately 124,234 shares of Gilead common stock, indicating she retained a substantial equity stake in the company despite the disposition.

Filing Facts

CIK

882095

Ticker

GILD

Form

4

Source Type

sec

Accession

0001782135-26-000024

Alert Tier

8

ATTN Analysis